| Net earnings | 1.58B |
| Depreciation and amortization | 615M |
| Stock-based compensation expense | 102M |
| Deferred income tax provision | -163M |
| Gain on discontinued operations (Note 2) | |
| Other non-cash expense / (income), net | 10M |
| Receivables, net | -265M |
| Inventories, net | -121M |
| Accounts payable | -143M |
| Other current assets | 79M |
| Other current liabilities | -266M |
| Change in pension and postretirement assets and liabilities, net | |
| Net cash provided by operating activities | 1.14B |
| Capital expenditures | -909M |
| Acquisitions, net of cash received | 0 |
| Proceeds from divestitures | 275M |
| Other | |
| Net cash used in investing activities | -521M |
| Net issuance/ (repayments) of short-term borrowings | 1.53B |
| Long-term debt proceeds | 1.15B |
| Long-term debt repaid | -1.76B |
| Dividends paid | -801M |
| Proceeds from stock option exercises and other | |
| Net cash provided by financing activities | -830M |
| Effect of exchange rate changes on cash and cash equivalents | 29M |
| (Decrease) / Increase | -184M |
| Balance at beginning of period | |
| Balance at end of period | |